Advancing Brain Organoids from Research Models to Scalable Platforms

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 30 Sept, 16:05 UTC

In this GEN webinar, Joseph Shultz (VP of technical development and manufacturing, Ottimo Pharma) and Imroz Ghangas (VP of commercial sales, Asimov) discuss strategies for achieving high-performing clonal titers and advancing a dual-paratopic cancer immunotherapy from sequence to dosed patient in…

science

Sources

• T2Advancing Brain Organoids from Research Models to Scalable PlatformsFierce Biotech / Fierce Healthcare / MedCity / GEN30 Sept, 16:05